Previous 10 | Next 10 |
-- Includes SARS-CoV-2 Synthetic RNA Control with D614G Mutation -- Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the expansion of its infectious diseas...
Evercore ISI has added a healthy 19 stocks in a fresh resumption of its best SMID "core" ideas this month - the research team's very best small and mid-cap stocks. More news on: Cheniere Energy, Inc., WPX Energy, Inc., Chart Industries, Inc., Notable Calls, Healthcare stocks news, Energy s...
Twist Bioscience ( TWST -4.3% ) unit Twist Biopharma will collaborate with animal health therapeutics developer Invetx on novel antibody treatments for serious diseases in dogs and cats. More news on: Twist Bioscience Corporation, Healthcare stocks news, Read more ...
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Invetx, a pioneer in protein-based therapeutics for animal health, today announced a partnership for the engineering and opti...
-- Twist Collaborating with VUMC to Supply a Large Number of Genes and Antibody Fragments to Aid in their Research -- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, toda...
Twist Bioscience (NASDAQ: TWST ) president & CEO Emily Leproust sells a total of 20K shares for a total of ~$1M. More news on: Twist Bioscience Corporation, Healthcare stocks news, Read more ...
Twist Bioscience ( TWST +3.3% ) will collaborate with New York City-based computational biology shop EVQLV to discover novel antibody-based therapies. More news on: Twist Bioscience Corporation, Healthcare stocks news, Read more ...
Twist Bioscience (NASDAQ: TWST ) unit Twist Biopharma inks an agreement with Takeda Pharmaceutical Company (NYSE: TAK ) granting the latter a license to its panel of synthetic antibody phage display libraries for the discovery, validation and optimization of antibodies in Takeda’s p...
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced a partnership with Takeda Pharmaceutical Company Limited (Takeda) for access to proprietary phage display librari...
Twist Bioscience ( TWST +5.4% ) launches Twist Respiratory Virus Research Panel , next-generation sequencing (NGS) for detection of a range of respiratory diseases, designed from reference sequences for 29 common human respiratory viruses. More news on: Twist Bioscience Corporati...
News, Short Squeeze, Breakout and More Instantly...
Twist Bioscience Corporation Company Name:
TWST Stock Symbol:
NASDAQ Market:
Twist Bioscience Corporation Website:
Pure Biologics’ exploratory Phase 0 study to evaluate pharmacodynamic activity of PBA-0405 in solid tumors Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today a...
Company to host conference call at 8:00 AM ET Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will issue its financial results for the fiscal 2024 th...
Express Genes enable faster turnaround times Twist Express Antibodies, CHO starting at 13 business days Twist Express Antibodies, HEK293 starting at 10 business days Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of ...